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Uncoupling protein 1 (UCP1) is an integral membrane protein found in the mitochondrial inner membrane
of brown adipose tissue, and facilitates the process of non-shivering thermogenesis in mammals. Its
activation by fatty acids, which overcomes its inhibition by purine nucleotides, leads to an increase in the
proton conductance of the inner mitochondrial membrane, short-circuiting the mitochondrion to produce
heat rather than ATP. Despite 40 years of intense research, the underlying molecular mechanism of UCP1 is
still under debate. The protein belongs to the mitochondrial carrier family of transporters, which have
recently been shown to utilise a domain-based alternating-access mechanism, cycling between a cyto-
plasmic and matrix state to transport metabolites across the inner membrane. Here, we review the protein
properties of UCP1 and compare them to those of mitochondrial carriers. UCP1 has the same structural fold
as other mitochondrial carriers and, in contrast to past claims, is a monomer, binding one purine nucle-
otide and three cardiolipin molecules tightly. The protein has a single substrate binding site, which is
similar to those of the dicarboxylate and oxoglutarate carriers, but also contains a proton binding site and
several hydrophobic residues. As found in other mitochondrial carriers, UCP1 has two conserved salt
bridge networks on either side of the central cavity, which regulate access to the substrate binding site in
an alternating way. The conserved domain structures and mobile inter-domain interfaces are consistent
with an alternating access mechanism too. In conclusion, UCP1 has retained all of the key features of
mitochondrial carriers, indicating that it operates by a conventional carrier-like mechanism.
© 2017 Medical research Council. Published by Elsevier B.V. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Contents
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Uncoupling protein 1 (UCP1) is the deﬁning feature of brown fat
and is responsible for the unique thermogenic properties of the
tissue [1e3]. The protein catalyses the leak of protons across the
mitochondrial inner membrane, dissipating the electrochemical
proton gradient that would otherwise drive ATP production by ATP
synthase. As a result, the energy from the oxidation of respiratory
substrates is instead released as heat. Hence, substrate oxidation is
‘uncoupled’ from ADP phosphorylation. UCP1 is the original
uncoupling protein that deﬁned the name and, unlike its homo-
logues within the mitochondrial carrier family of metabolite
transporters (e.g. UCP2 and 3), is the only carrier that is undisputed
in having a proton leak function (see Refs. [4,5]). Brown fat that is
rich in UCP1 has long been known to facilitate non-shivering
thermogenesis in newborn mammals to help defend body tem-
perature against the cold. However, over recent years it has come to
prominence that the tissue is present in adult humans too [6,7].
Humans exhibit both ‘classical’ brown fat, with characteristics
similar to the developmental tissue studied in newborns, and
‘beige’ brown fat, a recruitable form in white adipose tissue (see
Ref. [8] for an overview); the major depots are found in the
supraclavicular region and the neck [6,9]. These tissues utilise UCP1
and, when activated (e.g. by cold exposure), have the potential to
contribute signiﬁcantly to whole-body energy expenditure
[7,10e12]. Notably, the occurrence of brown fat in humans corre-
lates with leanness [7,9,13]. In mice, thermogenesis by brown fat
has been shown to clear lipids and dispose of glucose from the
blood, reducing metabolic disease [14], while the genetic ablation
of brown fat [15], or UCP1 speciﬁcally [16], induces obesity.
Methods to encourage brown adipose tissue and, importantly,
activate thermogenesis via UCP1 in the absence of physiological
stimuli [11,17,18] could provide therapies to combat obesity and
related diseases [19].
UCP1 activity is well regulated in brown adipocytes, where it is
induced in response to cold exposure or over-feeding through the
sympathetic nervous system, facilitating adaptive thermogenesis
(see Ref. [20] for review). Signals from the brain stimulate the
release of catecholamines, such as noradrenaline, in innervated
brown adipose tissue, which activate adrenergic receptors (most
signiﬁcantly b3) in the plasma membrane of brown adipocytes to
initiate intracellular cAMP-dependent signaling (Fig. 1). Gas protein,
dissociated from stimulated receptors, activates adenylate cyclase,
increasing cellular cAMP, which leads to changes in UCP1 activity
both acutely and through transcriptional regulation of the UCP1
gene [21e23]. In the acute response, cAMP activates protein kinase
A, which, among several targets, is believed to phosphorylate
hormone sensitive lipase and the perilipin protein that protects
stored lipid droplets from lipase breakdown, activating and deac-
tivating them, respectively [20,24,25]. The resulting lipolysis of
triglyceride stores releases free fatty acids into the cytosol, which
act as a fuel for mitochondrial oxidation, and, importantly, as the
direct activator of UCP1 [26], switching on thermogenesis (Fig. 1).
UCP1 binds and is inhibited by cytosolic (Mg2þ-free) purine
nucleotide (see Ref. [27]), ATP and ADP being themost relevant. The
mechanism of how fatty acids activate UCP1 and overcome nucle-
otide inhibition is debated (see below).
Up-regulation of the UCP1 gene occurs as part of adaptive
thermogenesis following adrenergic stimulation. The signaling
process and regulation of UCP1 transcription is multifaceted (see
[21,23] for a review), involving the activation of the p38MAP kinase
pathway downstream of protein kinase A stimulation by cAMP. The
UCP1 gene has a complex enhancer region upstream of the pro-
moter, where cAMP response elements facilitate transcriptional
control [28]. The region contains binding sites for several nuclearPlease cite this article in press as: P.G. Crichton, et al., The molecular fea
carrier-like mechanism, Biochimie (2017), http://dx.doi.org/10.1016/j.biocreceptor transcription factors, including the peroxisome
proliferator-activated receptor g (PPARg), retinoic X receptor (RXR),
9-cis retinoic acid receptor (RAR) and thyroid hormone receptor
(TR), consistent with the transactivation of the UCP1 gene in
response to their respective ligands [23]. The active control of
expression, tied to physiological cues, means that UCP1 protein
concentrations in brown adipose tissue mitochondria can vary
signiﬁcantly. The protein is a relatively abundant mitochondrial
carrier in conventional brown fat mitochondria, even in warm
adapted animals. In cold adapted animals, however, UCP1 levels can
increase to represent as much as ~10% of the mitochondrial inner
membrane protein [29].
The features of the UCP1 protein ﬁrst started to emerge from
early studies with isolated mitochondria (see Ref. [30]). The
‘recoupling’ effect of nucleotides on mitochondrial respiration and
the demonstration of an externally-exposed GDP-binding site led to
the proposal that a ‘nucleotide binding protein’ was responsible for
the unusual ion transport properties of brown fat mitochondria
[31]. Ricquier and Kader [32] were ﬁrst to highlight a 32 kDa
mitochondrial protein that increases in concentration in associa-
tionwith cold acclimation, which corresponded to the same protein
in later 8-azido-ATP labeling studies identiﬁed to be responsible for
controlling energy dissipation [29]. The puriﬁcation of the protein,
ﬁrst by using immobilised nucleotide [33] and later by ‘negative
chromatography’ methods developed for the ADP/ATP carrier
[34,35], led to investigations into the properties of what was then
ﬁrst termed “uncoupling protein”. These studies revealed UCP1 as
an integral membrane protein like the ADP/ATP carrier but with
distinct nucleotide binding properties. Purine nucleotides (ATP,
ADP, GTP and GDP) speciﬁcally bind with high afﬁnity at low pH
(<6), stabilising the detergent-solubilised protein [35]. The stoi-
chiometry of nucleotide binding and oligomeric state of UCP1 was
also addressed, but has since been revised in our recent work (see
below and [36]). The identiﬁcation of the UCP1 gene and amino
acid sequence [37,38] conﬁrmed that UCP1 is related to the ADP/
ATP carrier, and is a member of the mitochondrial carrier family of
metabolite exchangers, which all share the same basic structure
and membrane topology [39e41]. They are composed of three
~100-amino acid homologous domains, each comprising two
transmembrane a-helices separated by a loop and small a-helix on
the matrix side [41]. The ﬁrst helix of each domain contains the
signature motif PX[DE]XX[RK], which is well conserved across the
protein family. Following the reconstitution of isolated UCP1 into
liposomes, key characteristics associated with the uncoupling ac-
tivity of isolated brown adipose tissue mitochondria could be
demonstrated [42e44]. Namely, proton conductance activated by
fatty acids, which can be inhibited by nucleotides. However, despite
many studies over the years, the molecular mechanism of UCP1 has
not been resolved.
2. Proposed mechanisms of UCP1 activation
There have been many claims for various cellular metabolites
interacting with and regulating UCP1, however, most are contro-
versial and are likely to relate to the many technical difﬁculties in
studying this type of protein (see “Unsubstantiated mechanistic
and structural claims” below). What is clear is that proton
conductance by UCP1 is activated by free fatty acids and inhibited
by purine nucleotides. Several models have been proposed to
explain the interplay that occurs with these effectors, each derived
from observations largely based on different methodological ap-
proaches. Studies with isolated mitochondria have suggested that
fatty acids and nucleotides inﬂuence uncoupling activity with
simple competitive kinetics [45,46], supporting a ‘functional
competition’ model (Fig. 2A). In this proposal, fatty acids act ontures of uncoupling protein 1 support a conventional mitochondrial
hi.2016.12.016
Fig. 1. Signaling and acute activation of UCP1-dependent thermogenesis in brown adipocytes. Left: norepinephrine (NE) released in response to physiological stimuli (e.g. cold
exposure or overfeeding) activates a cAMP-dependent pathway leading to the release of fatty acids from cellular lipid stores. b3, b3-adrenergic receptor; Gs, Gas protein; AC,
adenylate cyclase; PKA, protein kinase A; HSL, hormone sensitive lipase. Right: free fatty acids interact to activate UCP1 in mitochondria, overcoming inhibition of the protein by
cytosolic purine nucleotides. Activated UCP1 catalyses the leak of protons across the mitochondrial inner membrane, dissipating the electrochemical proton gradient generated by
the respiratory chain that would otherwise drive ATP synthesis. As a result, the energy from the oxidation of respiratory substrates is released as heat.
Fig. 2. Proposed mechanisms of proton transport by UCP1. A) The functional
competition model: fatty acids act simply to remove nucleotide inhibition of UCP1,
either by direct competition or allosterically [45]. B) The cofactor model: fatty acids
associate with UCP1 to provide carboxylate(s) as protonatable groups, which complete
a proton transfer pathway within the protein [47]. C) The cycling model: fatty acid
anions act as actual transport substrate of UCP1 and are exported, ﬂipping back across
the membrane in a protonated state independently of UCP1, to give net proton transfer
[49,50]. D) The shuttling model: both protonated or deprotonated fatty acid species
can be transported/exchanged by UCP1, however, a restricted ability to release hy-
drophobic long chain fatty acids from the protein results in net proton transfer only
[57]. See main text for details.
P.G. Crichton et al. / Biochimie xxx (2017) 1e16 3UCP1 purely to remove nucleotide inhibition, either by direct
competition at the nucleotide-binding site or allosterically through
binding at a separate site [45], to allow net proton transfer by an
undeﬁned process. In the absence of either regulator, however, the
model predicts UCP1 to be inherently active, which is not consis-
tent with observations with the isolated protein. In liposomes,
UCP1 proton conductance does not occur without the addition of
fatty acids [47,48], and apparent activator-free activity in isolated
mitochondria is likely to relate to endogenous fatty acids from the
breakdown of lipids by lipases [48]. Furthermore, in contrast to the
situation with isolated mitochondria, fatty acids do not appear to
alter the afﬁnity of reconstituted UCP1 for nucleotides [47,48].
Studies predominantly with liposomes have led to two models
of UCP1 proton transport, the ‘cofactor’ model and the ‘cycling’
model, both relying on fatty acids as an essential component in the
process. In the cofactor model (Fig. 2B), fatty acids associate with
UCP1 to provide one or more carboxylate groups to complete a
proton transfer pathway within the protein, allowing transport
across themembrane [47]. Consistent with a central role of the fatty
acid carboxylate, the pH dependence of UCP1 activity correlates
well with the pKa of the activating fatty acid used [47]. Alterna-
tively, in the cycling model (Fig. 2C), fatty acid anions act as the
actual transport substrate of UCP1 and are exported, ﬂipping back
across the membrane in a protonated state independently of UCP1,
leading to a net proton transfer [49,50]. This model is supported by
the well-established observation that UCP1 transports chloride and
other monovalent anions too [51,52]. Of particular relevance, the
protein can transport various alkyl-sulfonate anions, low pKa ana-
logues of fatty acids, with rates similar to the proton conductance
induced by equivalent fatty acid species [50]. These analogues do
not induce proton conductance by UCP1, consistent with their
inability to be protonated at physiological pH and ﬂip back across
the membrane in accordance with the model [50]. It was claimed
that other analogues, such as glucose-O-u-palmitate, can also
activate UCP1 proton conductance but are unable to ﬂip across the
membrane due to the hydrophilic moiety at the end of the acyl tail,
providing evidence against the cycling model [27,53]. However, the
data were not substantiated and later work suggested that the
hydrophilic moiety does indeed interfere with the ability of the
compound to activate proton conductance by UCP1, contradictingPlease cite this article in press as: P.G. Crichton, et al., The molecular fea
carrier-like mechanism, Biochimie (2017), http://dx.doi.org/10.1016/j.biocthe claim [54]. Other arguments against the model rely on obser-
vations that anion (chloride) transport rates are too low to supporttures of uncoupling protein 1 support a conventional mitochondrial
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anion transport underlying the proton transport mechanism.
However, as pointed out [56], chloride may be a poor representa-
tive anion for transport by UCP1, as fatty acid-like anions are
transported at much faster rates.
More recently, patch clamp studies on mitochondrial inner
membranes from brown adipose tissue have provided evidence for
an alternative model, which has elements of both the cofactor and
cycling hypotheses. The ‘shuttling model’ [57] (Fig. 2D) contends
that fatty acids are effectively transport substrates, as in the cycling
model, but that either protonated or deprotonated fatty acid spe-
cies are exchanged by UCP1, i.e UCP1 has both fatty acid uniport
and fatty acid/Hþ symport activity. A restricted ability to release
long chain fatty acids from the protein on either side of the
membrane due to their hydrophobicity results in net proton
transfer dependent on the UCP1-associated fatty acid carboxylate,
reminiscent of the cofactor model. As such, long chain fatty acids
act to ‘shuttle’ protons through UCP1. Long chain fatty acids
induced continuous Hþ currents via UCP1 in patch clamp re-
cordings, whereas the currents induced by equivalent alkyl sulfo-
nates were carried by alkyl sulfonate movement and found to be
transient, consistent with anion transport that is restricted by
product build up on one side of the membrane. Accordingly,
decreasing the alkyl sulfonate acyl chain length or adding a binding
agent to increase the solubility of the species in the aqueous phase
could convert transient currents into continuous ones, consistent
with full anion transport and the previously proposed cycling
model. Of particular signiﬁcance, however, was the observation
that long chain alkyl sulfonates were only potent in inducing cur-
rents when introduced to UCP1 from the cytoplasmic side, which is
not consistent with the cycling model where fatty acid anion
binding at the matrix side for export to the cytosol would be ex-
pected to be favoured (cf. Fig. 2C). As such, the shuttling model
proposes the binding and transport of the protonated species from
the cytosol via UCP1 as well to accommodate these observations.
Why the hydrophobic protonated species would favour or rely on
UCP1 for this part of the transport cycle, however, rather than
ﬂipping directly across the membrane, which they can do rapidly
[58], is not clear.
The considerable research efforts outlined here along with the
corresponding models have made signiﬁcant advances to explain
the biochemical process of how UCP1 may mediate fatty acid
activated proton conductance. However, a robust molecular and
structural context for UCP1 is essential to provide the necessary
framework and constraints to clarify how the protein is likely to
function.
3. Unsubstantiated mechanistic and structural claims
There have been many high proﬁle claims regarding UCP1,
which have been refuted or not substantiated by others, particu-
larly on the activation of the protein by various metabolites.
Notably, ubiquinone (but not ubiquinol) was reported by Echtay
et al. [59,60] to be an obligatory cofactor, necessary for proton
conductance by recombinant UCP ‘refolded’ from bacterially pro-
duced inclusion bodies. However, the ﬁnding could not be repro-
duced in similar investigations by others [61], and was further
disproved through the study of UCP1 expressed in a strain of yeast
unable to make ubiquinone [62]. The bacterially produced UCP
material may have generated experimental artefacts, particularly
with the use of indirect ﬂuorescent methods to assess nucleotide
binding and protein integrity in the absence of parallel native
protein controls (see discussion below). Nevertheless, at the time,
the work was the impetus for further studies into related putative
activators of UCPs. Subsequent work (see Echtay et al. [63])Please cite this article in press as: P.G. Crichton, et al., The molecular fea
carrier-like mechanism, Biochimie (2017), http://dx.doi.org/10.1016/j.biocreported that superoxide, instead, activated UCP1, 2 and 3 based on
proton leak measurements with isolated mitochondria from
various tissues. The claimwas further revised to suggest 4-hydroxy-
2-nonenal, a lipid breakdown product downstream of superoxide
interactionwith lipid membranes, was the actual activating species
[64]. In either case, the activation of mild uncoupling by UCPs to
attenuate the production of reactive oxygen species at high mito-
chondrial membrane potential was proposed as a feedback mech-
anism to defend against oxidative stress. Although an attractive
hypothesis, other groups were not able to corroborate the claim. In
several similar studies with isolated mitochondria, no evidence
that either superoxide or 4-hydroxy-2-nonenal activated proton
leak by UCPs could be found [65e68]. Furthermore, the study of
mice with lower superoxide levels, due to the overexpression of
superoxide dismutase, did not show decreased proton leak by UCPs
(neither by UCP1 nor UCP3) as would be expected, suggesting that
endogenously generated superoxide does not regulate UCP activity
[69]. Physiological arguments have also been put forward to sug-
gest that UCP activation in this manner is unlikely [70,71]. More
recently, patch clamp investigations on mitochondrial inner
membranes from brown adipose tissue have clariﬁed that 4-
hydroxy-2-nonenal has no effect on proton transport by UCP1 [57].
The proposal that UCP1 is activated by reactive oxygen species
has resurfaced recently in a study by Chouchani et al. [72]. The
authors correlated an increase in reactive oxygen species with the
onset of thermogenesis in brown adipose tissue of mice kept in the
cold, and reported that antioxidants inhibit UCP1-dependent heat
production leading to hypothermia. In this study, direct activation
of UCP1 by reactive oxygen species was purported to occur through
the formation of a sulfenic acid adduct at C253 in UCP1. In addition
to the preceding studies that refute a role of reactive oxygen species
in activating UCPs [65e71], issues have been raised in response to
this work (see Ref. [73]), most notably with regards to the experi-
mental approach used and limited clarity on the link from whole-
animal physiology observations to a sulfenylation mechanism of
one speciﬁc residue of UCP1. Many other mitochondrial carriers
that are crucial for the function of the mitochondrion, such as the
mitochondrial ADP/ATP carrier, dicarboxylate carrier, oxodi-
carboxylate carrier, citrate carrier, and aspartate/glutamate carrier,
have cysteine residues in similar positions as C253 in the matrix a-
helices. They are not essential for function (see supplemental in-
formation in Ref. [74]), and substitutions, such as serine, threonine
or alanine, are commonly found. These residues are hidden in the
cytoplasmic state and exposed in the matrix state [74,75] and their
modiﬁcation by sulfhydryl reagents leads to irreversible inactiva-
tion of mitochondrial carriers [74]. In brown adipose mitochondria,
UCP1 is more abundant than other mitochondrial carriers and
sulfenylation, which is indiscriminate, would need to happen on a
large scale for regulation to be effective without affecting the ac-
tivity of many essential mitochondrial carriers, which also have
equivalent cysteine residues. Our measurements of the total mass
of native UCP1, puriﬁed from brown adipose tissue of newborn
lambs, have not revealed any evidence of sulfenylation (unpub-
lished data, Ian Fearnley). The observations of Chouchani et al. [72]
could simply relate to false positives generated by the indirect
methods used to detect sulfenic acid modiﬁcations.
As discussed above, UCP material generated in Escherichia coli
and refolded was responsible for the refuted claims that ubiqui-
none acts as a cofactor [59,60]. Many other studies have also used
recombinant material produced in E. coli to report on the behaviour
of UCPs [76e82]. For example, UCP1 has been claimed to self-
assemble to form tetramers [80] or to have a nucleotide binding
site that can be accessed from both sides of the membrane [79].
James Chou and colleagues have also published several high proﬁle
NMR studies on mitochondrial carriers produced in a similartures of uncoupling protein 1 support a conventional mitochondrial
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Fig. 3. UCP1 is a monomer binding GDP with a 1:1 stoichiometry. (A) Assessment of
the molecular mass of UCP1 in 10MNG/cardiolipin by size exclusion chromatography
[36]. Inset shows the mass composition of the major peak. (B) The apparent molecular
mass of native UCP1 and ADP/ATP carrier in blue native gels [97]. Mitochondrial
membrane extracts from lamb brown adipose tissue (UCP1, left), rat liver (ADP/ATP
carrier, middle) and yeast mitochondria (monomer and covalently linked dimer of the
P.G. Crichton et al. / Biochimie xxx (2017) 1e16 5
Please cite this article in press as: P.G. Crichton, et al., The molecular fea
carrier-like mechanism, Biochimie (2017), http://dx.doi.org/10.1016/j.biocmanner, including a backbone structure of UCP2 [78,82e84]. In
E. coli, recombinant mitochondrial carriers and UCPs are expressed
as inclusion bodies, which must be solubilized and refolded in
detergent following puriﬁcation. Typically, the protein is either
extracted directly with a zwitterionic detergent, e.g. Fos-Choline-
12, also called dodecylphosphocholine (DPC), or solubilized in a
known harsh detergent and exchanged into a milder one. Impor-
tantly, we, and others, have raised concerns on the structural
integrity and functionality of membrane proteins produced in this
way. Molecular dynamic simulations with the UCP2 structure and
tests with reconstituted UCP1 have shown that the structural
integrity of these proteins is compromised in Fos-Choline-12 mi-
celles (DPC) [85]. Through a detailed analysis of thermostability, we
have demonstrated that mitochondrial carriers from native sources
are relatively unstable, even in mild detergents [86]. Not only did
the zwitterionic detergent Fos-Choline-12 (DPC) destabilise native
UCP1, but it was also able to solubilize UCP1 from inclusion body
material and maintain the protein in a soluble but unfolded state.
As such, it is imperative that robust methods are applied to verify
the structural integrity and functionality of the material, particu-
larly with recombinantly produced protein. Unfortunately, as out-
lined in Ref. [86], commonly employed methods, such as
ﬂuorescence resonance energy transfer with nucleotide-
conjugated ﬂuorophores, monitoring tryptophan ﬂuorescence or
analysis of CD spectra, may give results that can be falsely inter-
preted to suggest the presence of folded carrier protein when
native material is not used as a control.4. UCP1 is a monomer binding one purine nucleotide
molecule
For many years it was thought that UCP1 formed a homo-dimer
based on analytical ultracentrifugation [87], nucleotide binding
[34,35,88,89] and protein cross-linking studies [35,90]. In fact, it
was believed that all mitochondrial carriers were dimers, but
subsequent studies have shown that these claims were incorrect
(see Ref. [91] for a review). Many of these earlier studies were
carried out in Triton X-100, which is difﬁcult to quantify and leads
to a large overestimation of the protein concentration in the
modiﬁed protein assays of Lowry [92]. Moreover, crosslinking of
UCP1 via the C-terminal cysteine (C304) does not happen in native
membranes unless oxidising conditions are applied [35,90]. We
decided to re-examine the oligomeric state of UCP1 by determining
the molecular mass of puriﬁed protein in decyl maltose neopentyl
glycol (10MNG) and cardiolipin micelles by size exclusion chro-
matography, as we have done for other carriers [93e96]. UCP1
eluted in the major peak corresponding to a total mass of the
protein/detergent/lipid micelle of 127 kDa (Fig. 3A) [36]. Since the
total mass is the sum of all components [94], the amounts of the
associated detergent and lipid were determined too, being 77 kDa
and 16 kDa, respectively (Fig. 3A, inset). Therefore, the protein was
34 kDa, which correlates well with the calculated mass of a single
UCP1 polypeptide of 33 kDa. The apparent mass of native UCP1 was
also analysed by blue native gel electrophoresis [97]. Under opti-
mised conditions the apparent masses of UCP1 and the ADP/ATP
carrier were found to be similar, approximately 66 kDa (Fig. 3B), but
they were monomeric nonetheless, as bound Coomassie, lipid and
detergent cause them to migrate anomalously in blue native gelsADP/ATP carrier AAC3, right) were prepared in 1% dodecylmaltoside and separated in
6e18% (w/v) polyacrylamide gels. (C) Isothermal titration calorimetry of puriﬁed UCP1
with GDP [36]. The enthalpy changes associated with the titration of GDP into UCP1 at
4 C (top), and corresponding isotherms ﬁtted to a one-site binding model with DH, Kd,
and stoichiometry as ﬁtting parameters (bottom).
tures of uncoupling protein 1 support a conventional mitochondrial
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Fig. 4. Three cardiolipin molecules are tightly bound to UCP1. (A) Endogenous cardiolipin co-puriﬁes with UCP1, as shown by the detection of unsaturated lipid, speciﬁcally,
following thin layer chromatography of lipid extracts from puriﬁed UCP1 after 300 mL washes in decylmaltoside supplemented with GDP plus 14:0 phosphatidylcholine (1) or 14:0
cardiolipin (2) [36]. (B) Lateral view of the yeast ADP/ATP carrier Aac2p showing binding of three cardiolipin molecules CDL800 (light blue), CDL801 (grey) and CDL802 (green)
[105]. The protein and cardiolipin molecules are shown in cartoon and ball-and-stick representations, respectively. The cardiolipin acyl chains have only been partially modelled. (C)
Detailed view of the binding site for cardiolipin molecule CDL801. Hydrogen bonds within the helices are shown as thin black dotted lines. Residues in the [YWF][KR]G and [YF]XG
motifs are shown in violet and green, respectively. Hydrogen bond interactions between protein and cardiolipin are shown as thick cyan dashed lines. The positive and negative
helical dipole are shown in blue and red, respectively. (D), (E), and (F) amino acid sequences of the cardiolipin binding sites of CDL800, CDL801, and CDL802, respectively, of the
mitochondrial ADP/ATP carrier and uncoupling protein from the following species: Bt, Bos taurus; Hs, Homo sapiens; Sc, Saccharomyces cerevisiae; Ml, Myotis lucifugus; Cf, Canis
familiaris; Et, Echinops telfairi; Rn, Rattus norvegicus; Mm, Mus musculus; Dg, Dicrostonyx groenlandicus; Ma, Mesocricetus auratus; Ps, Phodopus sungorus; Oa, Ovis aries; Bb, Bubalus
bubalis; Oc, Oryctolagus cuniculus; Od, Ochotona dauurica; Og, Otolemur garnettii and Pt, Pan troglodytes.
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Original observations with isolated UCP1 indicated that one
nucleotide is bound per two UCP1 [34], but this stoichiometry
might have been wrong due to the protein assay used (see above).
To obtain an accurate measure of the binding stoichiometry, we
used isothermal titration calorimetry. For this purpose, puriﬁed
UCP1, quantiﬁed by amino acid analysis, was titrated with known
concentrations of GDP and the resulting isotherms were ﬁtted with
an appropriate binding model, which demonstrated that 1.1 GDP
molecules bind per UCP1 with a Kd of 46 nM [36] (Fig. 3C). There-
fore, our data support a simple model where one UCP1 is capable of
binding one nucleotide inhibitor, just as one ADP/ATP carrier is
capable of binding one atractyloside or one carboxyatractyloside
inhibitor [41,98]. The other mitochondrial carriers that have been
examined have also proven to be monomeric [91,93e95] with the
exception of the mitochondrial aspartate/glutamate carrier, which
forms a dimer through extensive interactions of the N-terminal
regulatory domains, but the two carrier domains do not interact
[96]. In contrast to earlier claims, therefore, UCP1 functions as a
monomer.
5. UCP1 has three tightly bound cardiolipin molecules
Measurements using 31P NMR had previously indicated that
puriﬁed UCP1 does not bind cardiolipin [99], whereas the ADP/ATP
carrier binds three cardiolipin molecules [100]. Furthermore,
reconstitution studies had indicated that this lipid is not required
for UCP1 activity [101], but may alter the afﬁnity of the protein for
purine nucleotides [47,99]. In contrast, this mitochondrial lipid
does enhance the activity of mitochondrial carriers [102,103].
Using a new puriﬁcation procedure that allows the immobili-
sation of native UCP1, we discovered that endogenous cardiolipin
binds tightly to native UCP1, resisting removal by extensive deter-
gent washes (Fig. 4A) [36]. Quantiﬁcation showed that approxi-
mately six moles of lipid phosphorus were associated with UCP1,
consistent with UCP1 binding three molecules of cardiolipin [36].
Three cardiolipin molecules can be observed bound in all available
atomic structures of the mitochondrial ADP/ATP carrier [104,105]
(Fig. 4B). The key features of cardiolipin binding were deduced by
analysing the structures of 27 cardiolipin binding sites [104,105]
(Fig. 4C). First, the cardiolipin molecules are bound at the start of
the even-numbered and matrix a-helices, bridging the inter-
domain interface (Fig. 4C). Second, the conserved symmetrical
sequence motifs [YWF][RK]G and [YF]XG precede these a-helices.
The glycine residues of these motifs are in the loop to helix tran-
sitions, functioning as helix breakers. As a consequence, the amide
groups at the start of the a-helices are not involved in intra-helical
hydrogen bonding and instead use the phosphate groups of car-
diolipin as hydrogen bond acceptors. Third, the bound cardiolipin
molecules have two formal negative charges [106], which could be
compensated by the positive helix dipoles at the N-terminal end of
the even-numbered and matrix a-helices. There is no structural
evidence that the positively charged residues of the [YWF][RK]G
motif interact directly with the phosphate groups [105], as sug-
gested previously [99].
The aforementioned motifs are conserved in the equivalent sites
in UCP1 of different species (Fig. 4D, E, and F). In the human UCP1
the [YWF][RK]G and [YF]XGmotifs are YSG and YTG for the CDL800
site, FKG and YKG for the CDL801 site, and WKG and YKS for the
CDL801 site, respectively. All of the sequences have glycine residues
at the start of the even-numbered and matrix a-helices except for
the last motif where the glycine is replaced by a serine residue.
However, serine is also a common helix breaker as its side chain can
form a hydrogen bond with the backbone of the a-helix, consistent
with this notion. Therefore, in contrast to earlier claims, UCP1 doesPlease cite this article in press as: P.G. Crichton, et al., The molecular fea
carrier-like mechanism, Biochimie (2017), http://dx.doi.org/10.1016/j.biochave three tightly bound cardiolipin molecules that bridge the
inter-domain interfaces. Although the role of the cardiolipin mol-
ecules has not been resolved, they could be important for stability
of the carrier proteins by cross-linking the three domains on the
matrix side [36,41,86] and/or they could protect the dynamic inter-
domain interfaces (see also below) [105].
6. The substrate binding site of UCP1 and mitochondrial
carriers
Mitochondrial carriers consist of three homologous sequence
repeats [39,40] and they have a high degree of three-fold pseudo-
symmetry in their structures [41,98,105]. So it is likely that a
common ancestor of all mitochondrial carriers consisted of three
identical domains. Over time, different functions evolved through
mutations of key amino acid residues, introducing asymmetry
[107]. Since the substrates are not symmetrical, they require a site
with asymmetric residues for binding. In contrast, for the mainte-
nance of the three-fold symmetrical structure and mechanism,
symmetrical residues need to be conserved. Based on sequence
information only, a score was devised to assess the degree of
symmetry and conservation of all residues in mitochondrial car-
riers, including UCP1 [107]. For all known subfamilies conserved
asymmetric residues with the appropriate chemistry for substrate
binding were found to cluster in the central cavity, corresponding
roughly to the middle of the membrane [107]. For example, this
approach successfully identiﬁed the residues of the binding site in
the central cavity of the human mitochondrial ADP/ATP carrier
isoform 1, comprising the asymmetric residues G183, Y187, S228,
R236 and K23 (Fig. 5A) and the symmetric residues R80 and R280
(Fig. 5B), which couple substrate binding to a symmetric transport
mechanism. These residues have also been ﬂagged up by other
computational methods [103,108e110]. On either side of the cen-
tral cavity one can ﬁnd symmetric negatively and positively
charged residues, which form three-fold salt bridge networks (see
below) (Fig. 5B) [107].
UCP1 is one of the most symmetrical of all members of the
mitochondrial carrier family and it has very few highly conserved
asymmetric residues in the cavity (Fig. 5C). In human UCP1, the
most noteworthy residues are the asymmetric Q85 and D28
(Fig. 5C) and the symmetric R84, R183 and R277 (Fig. 5D) at the
contact points of the common substrate binding site [111,112]. The
asymmetric D28 is in the vicinity of the substrate binding site and
could be involved in proton transport [113]. The same symmetry-
related arginine triplet is also found in the dicarboxylate (Fig. 5E)
and oxoglutarate carriers [107]. Sequence and phylogenetic ana-
lyses have shown that UCP1 likely evolved from dicarboxylate
carriers and acquired a relatively small number of mutations in
adaptation to its new role in thermogenesis [107,114], which was a
relatively late development [115]. Based on this analysis it is not
clear whether UCP1 has lost its ability to transport dicarboxylates
all together, a function retained in UCP2 [116].
7. The binding of purine nucleotides to UCP1
Purine nucleotides inhibit UCP1 with high afﬁnity by binding
from the cytosolic side in a 1:1 inhibitor:protein stoichiometry [36].
However, in contrast to the ADP/ATP carrier (Fig. 5A) or GTP/GDP
transporters [107], symmetry analysis has not revealed large-scale
adaptations to accommodate nucleotide binding in UCP1. Nucleo-
tides most likely adopt a different orientation in this carrier protein.
Past proposals did not have the beneﬁt of a carrier structure as a
framework to guide interpretation of mutagenesis data (e.g.
Refs. [53,55,117]). With the beneﬁt of structural information
[41,105], we have described how nucleotides may interact withtures of uncoupling protein 1 support a conventional mitochondrial
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Fig. 5. Asymmetric and symmetric residues in the central cavity of mitochondrial carriers and uncoupling protein. Symmetry analysis was carried out on symmetry-related
residues of the human (A and B) mitochondrial ADP/ATP carrier, (C and D) uncoupling protein, (E and F) dicarboxylate carrier. Lateral views from the membrane are shown.
Conservation of the amino acid residues in the subfamily of orthologues is represented by the size of the sphere, whereas the average symmetry scores is represented by a colour
scale from highly asymmetric (red) to neutral (white) to symmetrical (blue). The asymmetric residues are all labelled (left panels) and the symmetrical contact points of the
substrate binding site are also labelled (right panels). The symmetrical residues belong to highly conserved motifs, such as the GXXXG and [FY]XX[YF] motifs and the charged
residues of the cytoplasmic and matrix salt bridge network.
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Fig. 6. Hydrophobic amino acid residues in the cavity of the carnitine/acylcarnitine carrier and uncoupling protein. Lateral view of the human carnitine/acylcarnitine carrier
CAC1 (left) and human uncoupling protein UCP1 (right), modelled on yeast Aac3p [105] and bovine AAC1 [41], both shown in cartoon representation. Substrate binding site, proton
binding site and hydrophobic residues (Gly, Ala, Val, Leu, Ile, Phe, Tyr, Trp, Met, and Cys) are shown in green, black and red ball-and-stick representations, respectively. Hydrophobic
residues in the cavity that are common to all mitochondrial carriers, such as those belonging to the GXXXG and [FY]XX[YF] motifs, were excluded in the analysis.
P.G. Crichton et al. / Biochimie xxx (2017) 1e16 9UCP1 [36]. Nucleotides most likely occupy the central cavity of
UCP1 in a similar manner to carboxyatractyloside inhibition of the
ADP/ATP carrier [41,105]. GDP increases UCP1 stability [86] and
resistance to trypsinolysis [118], much like the effects of carbox-
yatractyloside on the ADP/ATP carrier [119], consistent with inhi-
bition in the cytoplasmic state of the protein. In the carrier
substrate-binding site identiﬁed for UCP1 [112], the protein has a
triplet of arginine residues, related by three-fold pseudo-symmetry,
which would allow the binding of the phosphate moieties of the
nucleotide by electrostatic attractions. In support of this notion,
mutagenesis of these arginine residues in UCP1 abolishes nucleo-
tide binding [55,117]. Furthermore, other carriers that conserve
these arginine residues can also be inhibited by purine nucleotides,
albeit with much lower afﬁnity, such as the mitochondrial dicar-
boxylate carrier [120,121] or the oxoglutarate carrier (Dr. Magnus
Monne, unpublished results). Interaction of nucleotides with UCP1
in this manner would be consistent with the loss of binding
following the covalent modiﬁcation of E190 by Woodward's Re-
agent K [122]. This residue contributes to the pH regulation of
nucleotide inhibition and is predicted to face the central cavity of
UCP1, toward the cytosolic side, where adduct formation would
interfere with binding. Compared to the mitochondrial nucleotide
carriers, there are no speciﬁc adaptations in UCP1 for binding of the
bases [107], which could explain why there is little discrimination
between adenine and guanine moieties. However, if the phosphate
moieties bind to the arginine triplet, the purine base will be ori-
ented towards the cytoplasmic side of the central cavity where it
may have further interactions with other conserved residues (e.g.
E190 [123]).8. The binding of the fatty acid activator
There has been much debate on how fatty acids interact with
UCP1 to bring about proton conductance (see proposed mecha-
nisms, above). In describing the various models, the fatty acid acyl
chain is often depicted going through the side of UCP1 leaving thePlease cite this article in press as: P.G. Crichton, et al., The molecular fea
carrier-like mechanism, Biochimie (2017), http://dx.doi.org/10.1016/j.bioccarboxylic group in the central cavity (e.g. Refs. [55,57]). This kind
of arrangement is unlikely, however, as a channel would mean that
there is discontinuous electron density in the core of the mem-
brane. It would also impede any conformational changes. An
alternative proposal is that fatty acid anions bind to the outside
surface of UCP1 for transport across the membrane at the lipid-
protein interface as part of a cycling model, as suggested [124].
However, the outside of UCP1 is highly hydrophobic, as it is
imbedded in the membrane, and there are no obvious asymmetric
adaptations on the surface of the protein that could facilitate either
ionic or speciﬁc hydrophobic interactions with a transport
substrate.
The third possibility is that the fatty acid binds in the central
cavity as part of the mechanism. The triplet of arginine residues
could be the binding site for the carboxylate group, due to elec-
trostatic attractions. In the water phase of the cavity the hydro-
phobic acyl chain could have a minimised surface area, so the
volume could be quite small. The residues that interact with the tail
would have to be hydrophobic in nature. The mitochondrial
carnitine/acylcarnitine carrier (CAC1) transports fatty acids cova-
lently linked to carnitine and thus provides a good comparison for
the same logistical issues. This carrier has a fairly large number of
hydrophobic residues in the water-ﬁlled cavity (see Fig. 6), in
particular on transmembrane a-helix H2, which have been shown
to be important for substrate speciﬁcity [125]. On the whole the
total number of hydrophobic residues in the water-ﬁlled cavity of
UCP1 is quite similar (Fig. 6), but here they are mostly on trans-
membrane a-helix H6. On this basis it is certainly possible, but not
proven, that fatty acidmolecules are bound in the central cavity in a
similar position as the substrates in other mitochondrial carriers. If
true this scenario would imply that fatty acids would compete with
nucleotides to bind to UCP1, as has been suggested [45] (see
functional competition model), if fatty acids bind from the cytosol
[57]. Yet, paradoxically, fatty acids have also been shown to increase
the binding of a nucleotide derivative (mant-GDP) in pull down
experiments with isolated brown adipose tissue mitochondriatures of uncoupling protein 1 support a conventional mitochondrial
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Fig. 7. Main functional elements of the mitochondrial ADP/ATP carrier and uncoupling protein. A) The reversible transport states of the mitochondrial carrier named in blue.
Disruption and formation of the cytoplasmic and matrix salt bridge networks, top and bottom respectively, have been proposed to be involved in the opening and closing of the
carrier to either side of the membrane in an alternating way (107). B) Lateral view of the yeast ADP/ATP carrier Aac2p [105] and C) uncoupling protein 1, modelled on the yeast ADP/
ATP carrier Aac3p [105] and bovine AAC1 [41], both shown in cartoon representation. The proposed central substrate binding site (stick), the cytoplasmic salt bridge network (top,
ball-and-stick), and the matrix salt bridge network (bottom, ball-and-stick) are also shown. Positively charged, negatively charged and polar residues are shown in blue, red, and
green, respectively. Also shown on the right are the matrix (bottom) and cytoplasmic network (top) in schematic representations.
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Fig. 8. Conserved symmetrical elements of the mitochondrial ADP/ATP carrier and uncoupling protein. Lateral view of the yeast ADP/ATP carrier Aac2p [105] (left) and
uncoupling protein 1 (right), a comparative model using the yeast Aac3p [105] and bovine AAC1 [41] structures, in cartoon representation. Aromatic and hydrophobic residues of the
[FY]XX[YF] motif are shown in orange and pink ball-and-stick representations, respectively. Proline residues of the PX[DE]XX[KR] motif are shown in a magenta ball-and-stick
representations, whereas the serine residue in Aac2p, which mimics a proline residue, is shown in a green ball-and-stick representation. Positively charged residues, found two
positions after the PX[DE]XX[KR] motif, and negatively charged residues of the [ED]G motif are shown in blue and red ball-and-stick representations, respectively, whereas a
hydrophobic substitution of a positively charged residue in Aac2p is shown in pink.
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carrier, can increase inhibitor binding by shifting the isolated pro-
tein to the appropriate state through transport cycling [75] (i.e. by
increasing the rate of an otherwise inherently slow transition be-
tween cytoplasmic and matrix states). By analogy, shifting an
otherwise static mixed population of UCP1 between states by fatty
acid-induced cycling, would allow a cytoplasmic state conforma-
tion to be continuously sampled and only then the full nucleotide
binding site population realised. This scenario would explain the
fatty-acid induced increase in mant-GDP binding sites observed
previously where no change in nucleotide afﬁnity was apparent
[118], but only if fatty acids are accepted to be transport substrates
of UCP1. In our thermostability measurements with isolated carrier
protein, we have found that fatty acids induce similar destabilising
shifts in UCP1 as ADP does to the ADP/ATP carrier, which is also
sensitive to cardiolipin, suggesting fatty acids do indeed behave like
transport substrates [86].
9. UCP1 has a cytoplasmic and matrix salt bridge network
An alternating access transport mechanism for mitochondrial
carriers has been proposed on the basis of inhibitor and substrate
binding [126e128] as well as sequence and structural features
[105e107]. Mitochondrial carriers cycle between a cytoplasmic
state and matrix state in which the central substrate binding site is
alternately accessible to each of these compartments. Key elements
of this mechanism are two salt bridge networks on either side of
the membrane that regulate access to this site in an alternating way
(Fig. 7A) [107].
Charged residues of the signature motif PX[DE]XX[RK] form a
three-fold pseudo-symmetrical salt bridge network on the matrix
side when the carrier is in the cytoplasmic state [41,129]. Beneath
the network, bracing both residues of the salt bridges by hydrogen
bonds, are conserved glutamine residues [105] (Fig. 7B). Mito-
chondrial carriers have different numbers of glutamine braces,
thereby modulating the overall interaction energy of the matrix
network. The matrix network of UCP1 has three salt bridges andPlease cite this article in press as: P.G. Crichton, et al., The molecular fea
carrier-like mechanism, Biochimie (2017), http://dx.doi.org/10.1016/j.biocone glutamine brace (Fig. 7C), just like the ADP/ATP carrier (cf.
Fig. 7B).
Analysis of the pseudo-symmetry of mitochondrial carriers and
UCP1 revealed a highly conserved and symmetrical [FY][DE]XX[RK]
motif on the cytoplasmic side of the carrier (Fig. 7), which also has
the propensity to form a salt bridge network [107]. In the cyto-
plasmic state the charged residues are not engaged in interactions
[41,105], but they form a cytoplasmic salt bridge network when the
carriers are in the matrix state [75,105]. The residues of the cyto-
plasmic network are located on the even-numbered a-helices,
whereas those of the matrix network are on the odd-numbered a-
helices. Both networks are at the water-membrane interface on
either side of the carrier, where solute access to the central sub-
strate binding site may be controlled. In the mechanism, substrate
binding in one conformation allows the conversion to the other
conformation by the disruption and formation of these networks,
causing the alternating opening and closing of the carrier to either
side of the membrane (Fig. 7A). UCP1 has a cytoplasmic network
similar to that of the ADP/ATP carrier of yeast, consisting of two salt
bridges and one hydrogen bond (Fig. 7B and C). The complete
conservation of both salt bridge networks in UCP1 suggests that it
also has an alternating access mechanism. In agreement with this
notion it has been shown that stability and proteolysis sensitivity
changes in the presence of fatty acids, suggesting that UCP1 cycles
between states [86,118].
10. UCP1 has other conserved symmetrical features
compatible with a dynamic carrier-like mechanism
Symmetry analysis has highlighted other highly conserved
symmetrical features of mitochondrial carriers and UCP1 [107],
which are likely to be important for the three-fold pseudo-sym-
metrical structure and mechanism.
One of the symmetrical features are the proline residues of the
aforementioned motif PX[DE]XX[RK], which are found at the kinks
of the L-shaped odd-numbered a-helices [41] (Fig. 8). The proline
residues break the hydrogen bonding arrangement of the helices,tures of uncoupling protein 1 support a conventional mitochondrial
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Fig. 9. Uncoupling protein 1 has retained residues consistent with a dynamic inter-domain interface. A) Schematic representation of the a-helical arrangement of mito-
chondrial carriers in the cytoplasmic (left) and matrix state (right), caused by rotation of the three domains [105]. The smooth surfaces of the odd numbered helices are shown in
magenta, whereas the hydrophilic and hydrophobic residues of the even-numbered a-helices are represented by blue and brown boxes, respectively. The formation of the
cytoplasmic salt bridge network is also shown. B) and C) The structures of the ADP/ATP carrier (left) and uncoupling protein 1 (right), viewed from the cytoplasmic side. Domain 1, 2
and 3 are coloured blue, yellow, and red, respectively. B) Residues of the odd-numbered a-helices in the inter-domain interface have no or small side chains, including the residues
of the conserved GXXXG motif (shown in magenta and labelled). (C) Residues of the even-numbered a-helices in the inter-domain interface are hydrophobic (brown), facing the
membrane, or hydrophilic (blue), facing the cavity.
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tution in the second domain of the yeast ADP/ATP carriers forms a
hydrogen bondwith the backbone, mimicking proline (Fig. 8) [105].
UCP1 has three proline residues, indicating that it also has L-shaped
a-helices. It has been proposed that the L- shape allows formation
and disruption of the matrix salt bridge network to be coupled to
the disruption and formation of the cytoplasmic salt bridge
network in an alternating way [105].
A second set of highly conserved symmetrical features are res-
idues of the [FY]XX[YF] motif, which precede those of the cyto-
plasmic network. Although residues of this motif are largely
aromatic, hydrophobic substitutions are also found. Due to their
position, it has been proposed that formation of the cytoplasmic
salt bridge network in the matrix state would bring these residues
together to form a hydrophobic layer as part of the gate that closes
the carrier to the cytoplasmic side [130,131]. The residues of UCP1
in these positions are either hydrophobic or aromatic, and so they
could form an equivalent hydrophobic layer, consistent with a
carrier mechanism.
Highly conserved and symmetrical positively charged residues,
found two residue positions after the PX[DE]XX[KR] motif, interact
with the negatively charged residues of the symmetrical [ED]G
motif to link the C-terminal end of the odd-numbered a-helices
with the matrix a-helices. These interactions could stabilise the
structure of the domains, allowing its highly tilted shape. The
mitochondrial ADP/ATP carrier has one, possibly two, of these in-
teractions [41,105], as one is prevented by a hydrophobic substi-
tution, whereas UCP1 has the propensity to form three of these
interactions, highlighting again that UCP1 is more symmetrical. The
peculiar shape of the domains, which is maintained by this inter-
action, allows the opening and closing of the carrier to either side of
the membrane in an alternating way.
Finally, analyses of the inter-domain interfaces of mitochondrial
carriers have indicated that the even-numbered a-helices may
rotate across the surface of the odd-numbered a-helices as part of
the transport cycle (Fig. 9A) [105]. The helical surface of the odd-
numbered a-helices is smooth, as it has residues with short side
chains or glycine residues of the symmetrical GXXXG motif, which
is conserved in the mitochondrial ADP/ATP carrier and uncoupling
protein (Fig. 9B). On the even-numbered a-helices in the interface,
hydrophobic residues face the membrane whereas hydrophilic
residues face the cavity, neither pointing towards the interface,
which is also conserved in both proteins (Fig. 9C). The conservation
of these features in the inter-domain interface indicates that UCP1
has retained the ability to execute these dynamic changes as part of
its mechanism. The three tightly bound cardiolipin molecules will
span this interface and hold the domains together at thematrix side
during these rotations.
11. Conclusions
In this review we have investigated the sequence and protein
properties of UCP1 and compared them to those of other members
of the mitochondrial carrier family. UCP1 functions as a monomer,
binds a single purine nucleotide as part of its regulation, and has
three tightly bound cardiolipinmolecules that are important for the
stability and mechanism of this membrane protein [36,86].
Sequence and phylogenetic analyses have shown that UCP1 likely
evolved from dicarboxylate carriers and acquired a relatively small
number of mutations in adaptation to its new role in thermogenesis
[107], which was a relatively late development [114]. Remnants of
its function as a dicarboxylate carrier are the symmetric arginine
triplet and Q85 in its substrate binding site [107]. Among the most
striking adaptations, away from that function, are D28 and E190,
which could be key residues for binding of protons and purinePlease cite this article in press as: P.G. Crichton, et al., The molecular fea
carrier-like mechanism, Biochimie (2017), http://dx.doi.org/10.1016/j.biocnucleotides, respectively. Another possible adaptation is a number
of hydrophobic residues in the central water-ﬁlled cavity, which
could facilitate the binding of the acyl chain moiety of fatty acids.
We have also examined whether key features of an alternating
access mechanism have been retained in UCP1. UCP1 has two salt
bridge networks on either side of the central substrate binding site
[107], indicating that formation and disruption of these networks is
important for UCP1 function. They also have conserved prolines to
preserve the L-shaped odd-numbered a-helices, [RK] … [ED]G in-
teractions to preserve the shape of the domain, a hydrophobic layer
as part of the cytoplasmic gate, and dynamic inter-domain in-
terfaces, all pointing towards a dynamic mechanism in which the
three domains rotate to link the disruption and formation of these
two networks.
After reviewing all of the highly conserved protein features of
UCP1, it is clear that all of the key functional properties of mito-
chondrial carriers are conserved. Taken together they may indicate
that fatty acid activated proton conductance by UCP1 may have a
carrier-like mechanism. Alternatively, these conserved features
could reﬂect an additional more conventional transport function of
the protein.References
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